Original InvestigationFrailty in Older Adults Undergoing Aortic Valve Replacement: The FRAILTY-AVR Study
Central Illustration
Key Words
Abbreviations and Acronyms
Cited by (0)
The FRAILTY-AVR Study was funded by an Operating Grant from the Canadian Institutes for Health Research, a Clinical Research Scholars Award from the Fonds de Recherche du Québec en Santé, and a Research Fellowship Award from the Heart and Stroke Foundation of Canada. Dr. Lauck has served as a consultant to Edwards Lifesciences. Dr. D. Kim has served as a consultant to Alosa Health (nonprofit). Dr. Lefèvre has been a proctor for Edwards Lifesciences. Dr. Piazza has served as a consultant to Highlife, Microport, Boston Scientific, and Medtronic. Dr. Martucci has served as a consultant to Boston Scientific; and has been a proctor for Boston Scientific and Medtronic. Dr. Peterson has been a proctor for Edwards Lifesciences; and has served as a consultant for Edwards Lifesciences and LivaNova. Dr. Arora has received an unrestricted educational grant from Pfizer; has received honoraria from Mallickrodt Pharmaceutical; and has served on the advisory board for CSU-ALS North America. Dr. Palacios has served on the advisory boards of Medtronic, Abbott Vascular, Siemens, Abiomed, St. Jude Medical, and Ample Medical; and has been a proctor for St. Jude Medical and Edwards Lifesciences. Dr. Généreux has been a proctor for Edwards Lifesciences and Medtronic; and has received speaker fees from Medtronic. Dr. Lindman has served on the advisory board of Roche Diagnostics; has served as a consultant to Medtronic, Edwards Lifesciences, and Roche Diagnostics; and has received grant support from Roche Diagnostics and Edwards Lifesciences. Dr. Asgar has served as a consultant to Edwards Lifesciences and Medtronic. Dr. Morais has served on the advisory boards of Pfizer and Astellas. Dr. Rudski has minor stock holding outside of a managed portfolio in General Electric. Dr. Popma has received institutional grants from Medtronic and Abbott Vascular; and has served on the advisory boards of Boston Scientific and Abbott Vascular. Dr. Webb has served as a consultant to Edwards Lifesciences and Abbott Vascular. Dr. Perrault has served as a consultant to Somahlution; and has served on the advisory board of Clearflow. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.